SBI Securities »

Entrada Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $15 2 7.50
2025-03-31 $9 1 9.00

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Apple (AAPL)
Micron Technology (MU)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Direxion Daily Semi Bull 3X ETF Etf (SOXL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)

View all positions for SBI Securities

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
Merck & Co
Vanguard Capital Management
MPM Oncology Impact Management
TCG Crossover Management
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
AQR Capital Management
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co

View all funds holding Entrada Therapeutics